130 related articles for article (PubMed ID: 24915852)
41. Anti-Candida Activity of New Azole Derivatives Alone and in Combination with Fluconazole.
Shi C; Liu C; Liu J; Wang Y; Li J; Xiang M
Mycopathologia; 2015 Oct; 180(3-4):203-7. PubMed ID: 25977140
[TBL] [Abstract][Full Text] [Related]
42. Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections.
Holbrook SYL; Garzan A; Dennis EK; Shrestha SK; Garneau-Tsodikova S
Eur J Med Chem; 2017 Oct; 139():12-21. PubMed ID: 28797882
[TBL] [Abstract][Full Text] [Related]
43. Multi-drug resistant oral Candida species isolated from HIV-positive patients in South Africa and Cameroon.
Dos Santos Abrantes PM; McArthur CP; Africa CW
Diagn Microbiol Infect Dis; 2014 Jun; 79(2):222-7. PubMed ID: 24726686
[TBL] [Abstract][Full Text] [Related]
44. [Susceptibility to miconazole and itraconazole of Candida strains isolated from hospitalized and outpatient clinic patients].
Kurnatowska AK; Kwaśniewska J
Wiad Parazytol; 2009; 55(4):415-23. PubMed ID: 20209818
[TBL] [Abstract][Full Text] [Related]
45. Antifungal activity of low molecular weight chitosan against clinical isolates of Candida spp.
Alburquenque C; Bucarey SA; Neira-Carrillo A; Urzúa B; Hermosilla G; Tapia CV
Med Mycol; 2010 Dec; 48(8):1018-23. PubMed ID: 20482450
[TBL] [Abstract][Full Text] [Related]
46. In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
Kratzer C; Tobudic S; Schmoll M; Graninger W; Georgopoulos A
J Antimicrob Chemother; 2006 Nov; 58(5):1058-61. PubMed ID: 16987867
[TBL] [Abstract][Full Text] [Related]
47. Azole-synergistic anti-candidal activity of altenusin, a biphenyl metabolite of the endophytic fungus Alternaria alternata isolated from Terminalia chebula Retz.
Phaopongthai J; Wiyakrutta S; Meksuriyen D; Sriubolmas N; Suwanborirux K
J Microbiol; 2013 Dec; 51(6):821-8. PubMed ID: 24385360
[TBL] [Abstract][Full Text] [Related]
48. Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.
Gualco L; Debbia EA; Bandettini R; Pescetto L; Cavallero A; Ossi MC; Schito AM; Marchese A
Int J Antimicrob Agents; 2007 Feb; 29(2):179-84. PubMed ID: 17175140
[TBL] [Abstract][Full Text] [Related]
49. Isolation of phenazine 1,6-di-carboxylic acid from Pseudomonas aeruginosa strain HRW.1-S3 and its role in biofilm-mediated crude oil degradation and cytotoxicity against bacterial and cancer cells.
Dasgupta D; Kumar A; Mukhopadhyay B; Sengupta TK
Appl Microbiol Biotechnol; 2015 Oct; 99(20):8653-65. PubMed ID: 26051670
[TBL] [Abstract][Full Text] [Related]
50. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
51. Possible mechanism of antifungal phenazine-1-carboxamide from Pseudomonas sp. against dimorphic fungi Benjaminiella poitrasii and human pathogen Candida albicans.
Tupe SG; Kulkarni RR; Shirazi F; Sant DG; Joshi SP; Deshpande MV
J Appl Microbiol; 2015 Jan; 118(1):39-48. PubMed ID: 25348290
[TBL] [Abstract][Full Text] [Related]
52. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
53. The In Vitro Effectiveness of Lactobacillus fermentum Against Different Candida Species Compared With Broadly Used Azoles.
Deidda F; Amoruso A; Nicola S; Graziano T; Pane M; Allesina S; Raiteri E; Del Piano M; Mogna L
J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S171-S174. PubMed ID: 27741168
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of synergistic anticandidal and apoptotic effects of ferulic acid and caspofungin against Candida albicans.
Canturk Z
J Food Drug Anal; 2018 Jan; 26(1):439-443. PubMed ID: 29389586
[TBL] [Abstract][Full Text] [Related]
55. [Isolation, identification and characterization of rice rhizobacterium Pseudomonas aeruginosa PA1201 producing high level of biopesticide "Shenqinmycin" and phenazine-1-carboxamide].
Zhou L; Jiang H; Jin K; Sun S; Zhang W; Zhang X; He YW
Wei Sheng Wu Xue Bao; 2015 Apr; 55(4):401-11. PubMed ID: 26211314
[TBL] [Abstract][Full Text] [Related]
56. Anticandidal activity of medicinal plants and Pseudomonas aeruginosa strains of clinical specimens.
Bora L
J Microbiol Immunol Infect; 2016 Apr; 49(2):276-80. PubMed ID: 25592881
[TBL] [Abstract][Full Text] [Related]
57. Antibiofilm Activity of Curcumin and Piperine and Their Synergistic Effects with Antifungals against
Tsopmene UJ; Tokam Kuaté CR; Kayoka-Kabongo PN; Bisso BN; Metopa A; Mofor CT; Dzoyem JP
Scientifica (Cairo); 2024; 2024():2025557. PubMed ID: 38449801
[TBL] [Abstract][Full Text] [Related]
58. Azole drug resistance in Candida species.
Warnock DW
J Med Microbiol; 1992 Oct; 37(4):225-6. PubMed ID: 1404317
[No Abstract] [Full Text] [Related]
59. The synergistic effect of minocycline and azole antifungal drugs against Scedosporium and Lomentospora species.
Yang F; Sun Y; Lu Q
BMC Microbiol; 2022 Jan; 22(1):21. PubMed ID: 35016611
[TBL] [Abstract][Full Text] [Related]
60. Interaction of Bacterial Phenazines with Colistimethate in Bronchial Epithelial Cells.
Mossine VV; Chance DL; Waters JK; Mawhinney TP
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
